Key Research in Cervical Screening

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Cervical Screening Annual Review
Cervical Screening Statistics

Research Literature Online Database

The NHS Cervical Screening Programme is based on sound research evidence. The following trials have been set up to address some of the issues around cervical screening:

These research studies have already reported and evidence from them is being used to inform the programme:

A comparison of automated technology and manual cervical screening (MAVARIC)

Cervical screening by cytology (smear tests) has proved an effective means of reducing death rate from cervical cancer and the introduction of Liquid Based Cytology (LBC) will benefit both women and cytoscreeners.

The use of automated technology may bring further benefits by making identification of abnormal cells easier. Instead of scanning an entire slide the cytoscreeners will be directed to 15-22 locations on a slide by computerised software.

MAVARIC is a randomised controlled trial set up in August 2005 to compare two automated cervical screening technologies with manual screening. Samples from women undergoing primary cervical screening will be randomly allocated to reading by manual screening alone or by one of two automated technologies backed up by manual screening.

The trial is expected to end in 2009 with results being published in 2011.

Attitudes of Black and Minority Ethnic Women

This Populus poll on attitudes to cervical cancer was commissioned by the NHS Cancer Screening Programme in November 2008. The results revealed that women from black, Asian and minority ethnic groups were less sure of their cervical cancer risk than white women. For more information, please contact the press office on 0207 400 4499.

Poll: Attitudes of Black and Minority Ethnic Women - November 2008 (PDF 224Kb)

The NHS Cancer Screening Programmes are not responsible for the content of external internet sites.


Search this site for:
Cervical Screening Publications

Cervical screening programme index

What happens at a
screening appointment?

Cervical cancer

Diethylstilbestrol (DES) exposed women

Liquid Based Cytology (LBC)

LBC implementation guidance

Who does what in the NHS Cervical Screening Programme

Frequently Asked Questions (FAQs)

Quality assurance

Programme statistics

Archived statistics bulletins

Cytology training

Human Papilloma Virus (HPV)

HPV Sentinel Sites

HMR 101 guidance notes

Research

Useful links

Publications

Programme posters

Archive

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

cervical/research.html
Designed and hosted by The Net Effect

This page validates to HTML 4.0This document validates as CSS!
©NHS Cancer Screening Programmes